Evidence map›Paper›PMID 36687035›Full record

ArticleACS omega2023

Changes in Length and Positive Charge of Palindromic Sequence RWQWRWQWR Enhance Cytotoxic Activity against Breast Cancer Cell Lines.

Andrea Carolina Barragán-Cárdenas, Diego Sebastián Insuasty-Cepeda, Yerly Vargas-Casanova, Joel Edmundo López-Meza, Claudia Marcela Parra-Giraldo, Ricardo Fierro-Medina, Zuly Jenny Rivera-Monroy, Javier Eduardo García-Castañeda

Abstract read
In one paragraph

Article in ACS omega, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Antifungal Synergy: Mechanistic Insights into the R-1-R Peptide andInternational journal of molecular sciences · 2024
    Article
  4. Evaluating theACS omega · 2023
    Article
  5. Combining the Peptide RWQWRWQWR and an Ethanolic Extract ofJournal of fungi (Basel, Switzerland) · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Andrea Carolina Barragán-CárdenasBiotechnology Institute, Universidad Nacional de Colombia, Carrera 45 No. 26-85, Building 224, Bogota 111321, Colombia.
Diego Sebastián Insuasty-CepedaChemistry Department, Universidad Nacional de Colombia, Carrera 45 No. 26-85, Building 451, Bogota 111321, Colombia.
Yerly Vargas-CasanovaMicrobiology Department, Pontificia Universidad Javeriana, Ak. 7 #40-62, Bogotá 110231, Colombia.
Joel Edmundo López-MezaMultidisciplinary Centre for Studies in Biotechnology, Universidad Michoacana de San Nicolás de Hidalgo, Km 9.5 Carretera Morelia, Zinapécuaro, Morelia 58030, Mexico.
Claudia Marcela Parra-GiraldoMicrobiology Department, Pontificia Universidad Javeriana, Ak. 7 #40-62, Bogotá 110231, Colombia.
Ricardo Fierro-MedinaChemistry Department, Universidad Nacional de Colombia, Carrera 45 No. 26-85, Building 451, Bogota 111321, Colombia.
Zuly Jenny Rivera-MonroyChemistry Department, Universidad Nacional de Colombia, Carrera 45 No. 26-85, Building 451, Bogota 111321, Colombia.ORCID https://orcid.org/0000-0001-6915-8488
Javier Eduardo García-CastañedaPharmacy Department, Universidad Nacional de Colombia, Carrera 45 No. 26-85, Building 450, Bogota 111321, Colombia.ORCID https://orcid.org/0000-0001-6882-4397

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Breast cancer is one of the main causes of premature death in women; current treatments have low selectivity, generating strong physical and psychological sequelae. The palindromic peptide R-1-R (RWQWRWQWR) has cytotoxic activity against different cell lines derived from cancer and selectivity against noncancerous cells. To determine if changes in the charge/length of this peptide increase its activity, six peptides were obtained by SPPS, three of them with addition of Arg at the N, C-terminal or both and three with deletion of Arg at the N, C-terminal or both. The cytotoxic and selective activities were evaluated against MCF-7, MDA-MB-231, and MCF-12 cell lines and fibroblast primary cell culture, evidencing that the RR-1-R peptide with the inclusion of Arg in the N-terminal end maintained selectivity and increased cytotoxicity against lines derived from breast cancer. The effect of this addition regarding the type of induced cell death was evaluated by flow cytometry, showing very low rates of necrosis and a significant majority of apoptotic events with activation of both Caspase 8 and Caspase 9. This work allowed us to find a modification that generates a peptide with greater cytotoxic effects and can be considered a promising molecule for other approaches to improve anticancer peptides.

Identifiers

PMID36687035
PMCPMC9850729

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.